Skip to main content
. 2023 Jul 28;30:129–141. doi: 10.1016/j.bioactmat.2023.07.015

Fig. 6.

Fig. 6

a) Wound pictures of control group (Tegaderm™ film dressing), OSD/CMC hydrogel, OSD/CMC/Fe/PA3 hydrogel and OSD/CMC/Fe/PA3 hydrogel + NIR on day 3, 7 and 14; b) Schematic diagram of the wound area of b1) control, b2) OSD/CMC hydrogel, b3) OSD/CMC/Fe/PA3 hydrogel, and b4) OSD/CMC/Fe/PA3 hydrogel + NIR for 14 days; c) Wound area of each group; d) Thickness of granulation tissue (orange arrow) in different groups on day 14. *P < 0.05, **P < 0.01, ***P < 0.001.